News / Science News

    Scientists Discover How Antiviral Gene Works

    It's been known for years that humans and other mammals possess an antiviral gene called RSAD2 that prevents a remarkable range of viruses from multiplying.



    Scientists Discover How Antiviral Gene Works.


    Now, researchers at Albert Einstein College of Medicine, part of Montefiore, have discovered the secret to the gene's success: The enzyme it codes for generates a compound that stops viruses from replicating. The newly discovered compound offers a novel approach for attacking many disease-causing viruses.

    The compound, called ddhCTP, disrupts the replication machinery of Zika virus. The next step is to test the compound against a broad array of viruses.

    Mammalian cells that become infected by viruses and other pathogens release signaling proteins called interferons. The interferons in turn trigger the expression of hundreds of genes -- one of which is RSAD2, the gene that codes for the enzyme viperin (short for "virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible").

    Studies have shown that viperin's expression inhibits a broad spectrum of disease-causing viruses, including hepatitis C, rabies and HIV-1.

    Researchers had proposed several theories for how viperin exerts its anti-viral effects, but precisely how it acted was a mystery. The current study reveals that viperin catalyzes the conversion of a nucleotide called CTP (cytidine triphosphate) into a structurally similar compound, or analog: the nucleotide ddhCTP -- a previously undescribed molecule that sabotages viral replication.

    Many viruses use CTP as a building block to synthesize the new strands of genetic material they need to replicate.

    The conversion of CTP to its analog, ddhCTP, throws a monkey wrench into virus' ability to copy its genome. The analogue's structure differs only slightly from CTP's -- but the difference is sufficient to bring viral replication to a halt.

    ddhCTP may be able to inhibit all flaviviruses, a class of viruses that includes Zika as well as dengue, West Nile, yellow fever, Japanese encephalitis and hepatitis C

    ddhCTP appears to be "a completely novel drug scaffold" for designing antiviral drugs. Those drugs would be based on a naturally occurring molecule, so they could have few off-target effects -- a common problem with manmade nucleotide analogs, which can be effective but also quite toxic. (Tasnim News Agency)

    JULY 2, 2018



    YOU MAY ALSO LIKE

    A map released by NASA's Near Earth Object Program reveals that small asteroids frequently enter and disintegrate in the Earth's atmosphere with random distribution around the globe. Released to the scientific community, the map visualizes data gathered by U.S. government sensors from 1994 to 2013.
    A newly discovered planet in a binary, or twin, star system located 3,000 light-years from Earth is expanding astronomers' notions of where Earth-like -- and even potentially habitable -- planets can form, and how to find them.
    Higher levels of a customary gut bacteria enhanced by breastfeeding in early infancy were found to be coupled with an improved response to vaccines in infants through two years of age.
    An exquisite, fascinating fossil find in northern China has provided new evidence that some Jurassic dinosaurs developed membranous wings like those seen in modern day bats.
    An international team of astronomers found that the unusual Kuiper Belt Object 2004 EW95 is a carbon-rich asteroid, the first of its kind to be confirmed in the cold outer reaches of the Solar System.
    Emerging fungal pathogens pose a greater threat to biodiversity than any other parasitic group, scientists say, causing population declines of amphibians, bats, corals, bees and snakes. Now, research results reveal that amphibians can acquire behavioral or immunological resistance to a deadly chytrid fungus implicated in global amphibian population declines.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact